272 related articles for article (PubMed ID: 31050747)
1. The Combination of 2'-Fucosyllactose with Short-Chain Galacto-Oligosaccharides and Long-Chain Fructo-Oligosaccharides that Enhance Influenza Vaccine Responses Is Associated with Mucosal Immune Regulation in Mice.
Xiao L; Engen PA; Leusink-Muis T; van Ark I; Stahl B; Overbeek SA; Garssen J; Naqib A; Green SJ; Keshavarzian A; Folkerts G; Van't Land B
J Nutr; 2019 May; 149(5):856-869. PubMed ID: 31050747
[TBL] [Abstract][Full Text] [Related]
2. Human Milk Oligosaccharide 2'-Fucosyllactose Improves Innate and Adaptive Immunity in an Influenza-Specific Murine Vaccination Model.
Xiao L; Leusink-Muis T; Kettelarij N; van Ark I; Blijenberg B; Hesen NA; Stahl B; Overbeek SA; Garssen J; Folkerts G; Van't Land B
Front Immunol; 2018; 9():452. PubMed ID: 29593719
[TBL] [Abstract][Full Text] [Related]
3. Sialylated galacto-oligosaccharides and 2'-fucosyllactose reduce necrotising enterocolitis in neonatal rats.
Autran CA; Schoterman MH; Jantscher-Krenn E; Kamerling JP; Bode L
Br J Nutr; 2016 Jul; 116(2):294-9. PubMed ID: 27212112
[TBL] [Abstract][Full Text] [Related]
4. Prebiotic oligosaccharides in early life alter gut microbiome development in male mice while supporting influenza vaccination responses.
van den Elsen LWJ; Tims S; Jones AM; Stewart A; Stahl B; Garssen J; Knol J; Forbes-Blom EE; Van't Land B
Benef Microbes; 2019 Apr; 10(3):279-291. PubMed ID: 30773928
[TBL] [Abstract][Full Text] [Related]
5. Human Milk Oligosaccharide 3'-GL Improves Influenza-Specific Vaccination Responsiveness and Immunity after Deoxynivalenol Exposure in Preclinical Models.
Toutounchi NS; Braber S; Hogenkamp A; Varasteh S; Cai Y; Wehkamp T; Tims S; Leusink-Muis T; van Ark I; Wiertsema S; Stahl B; Kraneveld AD; Garssen J; Folkerts G; Van't Land B
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579070
[TBL] [Abstract][Full Text] [Related]
6. A specific prebiotic oligosaccharide mixture stimulates delayed-type hypersensitivity in a murine influenza vaccination model.
Vos AP; Haarman M; Buco A; Govers M; Knol J; Garssen J; Stahl B; Boehm G; M'Rabet L
Int Immunopharmacol; 2006 Aug; 6(8):1277-86. PubMed ID: 16782540
[TBL] [Abstract][Full Text] [Related]
7. The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome.
Iribarren C; Magnusson MK; Vigsnæs LK; Aziz I; Amundsen ID; Šuligoj T; Juge N; Patel P; Sapnara M; Johnsen L; Sørensen N; Sundin J; Törnblom H; Simrén M; Öhman L
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836092
[TBL] [Abstract][Full Text] [Related]
8. Supplementation of Mice with Specific Nondigestible Oligosaccharides during Pregnancy or Lactation Leads to Diminished Sensitization and Allergy in the Female Offspring.
Hogenkamp A; Knippels LM; Garssen J; van Esch BC
J Nutr; 2015 May; 145(5):996-1002. PubMed ID: 25833889
[TBL] [Abstract][Full Text] [Related]
9. Dietary Human Milk Oligosaccharides but Not Prebiotic Oligosaccharides Increase Circulating Natural Killer Cell and Mesenteric Lymph Node Memory T Cell Populations in Noninfected and Rotavirus-Infected Neonatal Piglets.
Comstock SS; Li M; Wang M; Monaco MH; Kuhlenschmidt TB; Kuhlenschmidt MS; Donovan SM
J Nutr; 2017 Jun; 147(6):1041-1047. PubMed ID: 28490677
[No Abstract] [Full Text] [Related]
10. Supplementation with galacto-oligosaccharides increases the percentage of NK cells and reduces colitis severity in Smad3-deficient mice.
Gopalakrishnan A; Clinthorne JF; Rondini EA; McCaskey SJ; Gurzell EA; Langohr IM; Gardner EM; Fenton JI
J Nutr; 2012 Jul; 142(7):1336-42. PubMed ID: 22496400
[TBL] [Abstract][Full Text] [Related]
11. Altered microbial community structure and metabolism in cow's milk allergic mice treated with oral immunotherapy and fructo-oligosaccharides.
Vonk MM; Engen PA; Naqib A; Green SJ; Keshavarzian A; Blokhuis BRJ; Garssen J; Knippels LMJ; van Esch BCAM
Benef Microbes; 2020 Feb; 11(1):19-32. PubMed ID: 32066258
[TBL] [Abstract][Full Text] [Related]
12. A fermented milk concentrate and a combination of short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides/pectin-derived acidic oligosaccharides protect suckling rats from rotavirus gastroenteritis.
Rigo-Adrover M; Pérez-Berezo T; Ramos-Romero S; van Limpt K; Knipping K; Garssen J; Knol J; Franch À; Castell M; Pérez-Cano FJ
Br J Nutr; 2017 Jan; 117(2):209-217. PubMed ID: 28166850
[TBL] [Abstract][Full Text] [Related]
13. Dietary supplementation of neutral and acidic oligosaccharides enhances Th1-dependent vaccination responses in mice.
Vos AP; Haarman M; van Ginkel JW; Knol J; Garssen J; Stahl B; Boehm G; M'Rabet L
Pediatr Allergy Immunol; 2007 Jun; 18(4):304-12. PubMed ID: 17584310
[TBL] [Abstract][Full Text] [Related]
14. Fructo-oligosaccharide-Induced Transient Increases in Cecal Immunoglobulin A Concentrations in Rats Are Associated with Mucosal Inflammation in Response to Increased Gut Permeability.
Genda T; Sasaki Y; Kondo T; Hino S; Nishimura N; Tsukahara T; Sonoyama K; Morita T
J Nutr; 2017 Oct; 147(10):1900-1908. PubMed ID: 28835391
[No Abstract] [Full Text] [Related]
15. Butyrate interacts with the effects of 2'FL and 3FL to modulate
Zuurveld M; Diks MAP; Kiliaan PCJ; Garssen J; Folkerts G; Van't Land B; Willemsen LEM
Front Nutr; 2023; 10():1305833. PubMed ID: 38174112
[TBL] [Abstract][Full Text] [Related]
16. Specific prebiotic oligosaccharides modulate the early phase of a murine vaccination response.
Vos AP; Knol J; Stahl B; M'rabet L; Garssen J
Int Immunopharmacol; 2010 May; 10(5):619-25. PubMed ID: 20206301
[TBL] [Abstract][Full Text] [Related]
17. The human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine.
Good M; Sodhi CP; Yamaguchi Y; Jia H; Lu P; Fulton WB; Martin LY; Prindle T; Nino DF; Zhou Q; Ma C; Ozolek JA; Buck RH; Goehring KC; Hackam DJ
Br J Nutr; 2016 Oct; 116(7):1175-1187. PubMed ID: 27609061
[TBL] [Abstract][Full Text] [Related]
18. Post-sensitization administration of non-digestible oligosaccharides and
van Esch BC; Abbring S; Diks MA; Dingjan GM; Harthoorn LF; Vos AP; Garssen J
Immun Inflamm Dis; 2016 Jun; 4(2):155-165. PubMed ID: 27933160
[